Abstract
It is known that PKC is differently expressed in brain and the peripheral nervous system and is involved in cellular differentiation. We have analyzed 9 human neuronal-derived crest-cell lines for PKC-α mRNA. Seven out of nine expressed 9.0 kb and 4.0 kb PKC-α mRNAs but three had high level of 9.0 kb transcription. The different expression of the two messenger RNAs may result from alternative splicing and a different degree of cell maturation. The same cell lines were studied for MYCN gene expression. A possible relation between the two genes is discussed. One cell line expressing high levels of both PKC-α mRNA was treated with 10-1 M retinoic acid (RA). The expression of both messenger RNAs was suppressed when the cells achieved a morphological differentiation and showed neurite-like processes. A decrease of PKC-α gene expression was associated to down regulation of MYCN mRNA. These preliminary results suggest that PKC suppression of PKC-α mRNA is associated with reversion of the malignant phenotype.
Original language | English |
---|---|
Pages (from-to) | 221-224 |
Number of pages | 4 |
Journal | FEBS Letters |
Volume | 280 |
Issue number | 2 |
DOIs | |
Publication status | Published - Mar 25 1991 |
Keywords
- Gene expression
- Human neuroblastoma
- Neuronal differentiation
- PKC-α
- Retinoic acid
ASJC Scopus subject areas
- Biochemistry
- Biophysics
- Molecular Biology